|
CN106431878A
|
|
Method for purifying 10-chlorocapraldehyde
|
|
CN107219307A
|
|
The method that enantiomter impurity in song Ge Lieting bulk drugs and its preparation is determined using HPLC
|
|
CN106918671A
|
|
The method for determining DMAC N,N' dimethyl acetamide dissolvent residual in bulk drug
|
|
CN106918672A
|
|
Using the method in HPLC measure Chinese mugwort Fluconazole bulk drug and its preparation about material
|
|
CN106916147A
|
|
Compound and its production and use
|
|
CN106913528A
|
|
Eliquis micropill and preparation method thereof
|
|
CN106913859A
|
|
Pharmaceutical composition and preparation method
|
|
CN106916195A
|
|
The purification process of shellfish cholic acid intermediate difficult to understand
|
|
CN106902346A
|
|
Pharmaceutical composition and its pharmaceutical applications
|
|
CN106902347A
|
|
The purposes of close cyclosporine inhibitor
|
|
CN106908563A
|
|
Spotting system and method
|
|
CN106810586A
|
|
Shellfish cholic acid crystal formation II difficult to understand and its production and use
|
|
CN106810587A
|
|
The method for preparing unformed shellfish cholic acid difficult to understand
|
|
CN106807106A
|
|
Crystal system and method for crystallising
|
|
CN106810534A
|
|
Chinese mugwort Fluconazole crystal formation and preparation method thereof
|
|
CN106807114A
|
|
Taper chromatographic fractionation system and its method for isolating and purifying
|
|
CN106749322A
|
|
The method for separating Ofloxacin enantiomter
|
|
CN106733967A
|
|
Purging system and the method that bottle is cleaned using the purging system
|
|
CN106582289A
|
|
Filter system and filter method
|
|
CN106565672A
|
|
Method for preparation of Efinaconazole
|
